by InfluencER | Sep 24, 2021 | Pharma
A limited but growing number of states permit eligible patients to be reimbursed for their medical cannabis-related costs through their workers’ compensation insurance (WCI) plans, according to a just-published analysis of state policies conducted by the National...
by InfluencER | Sep 24, 2021 | Pharma
For years, cannabinoids, the chemicals found in the cannabis plant, have been widely known for their therapeutic and medicinal abilities. Scientists have identified at least 113 different chemicals in the plant — with tetrahydrocannabinol (THC) and cannabidiol (CBD) —...
by kmyatt | Sep 15, 2021 | Pharma, Politics and Law
U.S. health officials are warning about the potential dangers of “delta-8 THC,” a compound derived from marijuana, after seeing an increase in hospitalizations tied to the substance. On Tuesday (Sept. 14), both the Centers for Disease Control and...
by InfluencER | Sep 9, 2021 | Pharma
Combined sales of the three most lucrative cannabis pharmaceuticals products – Epidiolex®, Dronabinol, and Sativex® – are set to reach €1.8 billion by 2025, according to a new report. The Pharmaceutical Cannabis Report: 2nd Edition, released today by global cannabis...
by InfluencER | Sep 8, 2021 | Pharma
A new, updated study published Monday in the JAMA Network Open found “little evidence” that adult and medical use cannabis legalization “encourage youth marijuana use.” The study, conducted by researchers from the Department of Agricultural Economics at Montana State...
by InfluencER | Sep 3, 2021 | Pharma
Combined sales of the three most lucrative cannabis pharmaceuticals products – Epidiolex, Dronabinol, and Sativex – are set to reach €1.8 billion by 2025, according to a new report. The Pharmaceutical Cannabis Report: 2nd Edition, from global cannabis industry...
